posted on 2014-04-25, 00:00authored bySiwen Niu, Dong Liu, Xinxin Hu, Peter Proksch, Zhongzhe Shao, Wenhan Lin
Fifteen new depsidone-based analogues
named spiromastixones A–O (1–15) were isolated from the fermentation broth of a deep-sea Spiromastix sp. fungus. Their structures were elucidated
on the basis of extensive NMR and mass spectroscopic analysis in association
with chemical conversion. Spiromastixones A–O are classified
into two subtypes based on the orientation of ring C relative to ring
A, while the n-propyl substituents on rings A and
C are rarely seen in natural products. Most analogues are substituted
by various numbers of chlorine atoms. All compounds exhibited significant
inhibition against Gram-positive bacteria including Staphylococcus
aureus, Bacillus thuringiensis, and Bacillus subtilis with MIC values ranging from 0.125 to
8.0 μg/mL. In addition, compounds 6–10 displayed potent inhibitory effects against methicillin-resistant
bacterial strains of S. aureus (MRSA) and S. epidermidis (MRSE), while 10 also inhibited
the growth of the vancomycin-resistant bacteria Enterococcus
faecalis and E. faecium (VRE). The structure–activity
relationships are discussed.